HuaXMcDermottRLungTet al.Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort. Eur J Prev Cardiol2017; 24: 1660–1669.
2.
JinKGullickJNeubeckLet al.Acculturation is associated with higher prevalence of cardiovascular disease risk-factors among Chinese immigrants in Australia: evidence from a large population-based cohort. Eur J Prev Cardiol2017; 24: 2000–2008.
3.
ChrysohoouCSkoumasJGeorgiopoulosGet al.Exercise capacity and haemodynamic response among 12,327 individuals with cardio-metabolic risk factors undergoing treadmill exercise. Eur J Prev Cardiol2017; 24: 1627–1636.
4.
ShalaevaEVSanerHJanabaevBBet al.Tenfold risk increase of major cardiovascular events after high limb amputation with non-compliance for secondary prevention measures. Eur J Prev Cardiol2017; 24: 708–716.
5.
HansenDDendalePConinxKet al.The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: a digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology. Eur J Prev Cardiol2017; 24: 1017–1031.
6.
MontLPellicciaASharmaSet al.Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. Eur J Prev Cardiol2017; 24: 41–69.
7.
LettinoMLeonardiSDe MariaEet al.Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease. Eur J Prev Cardiol2017; 24(3 Suppl): 61–70.
8.
MattioliAVManentiAFarinettiA. Sex differences in adherence to guidelines in aspirin prescription in a population of low-risk cardiovascular patients. Eur J Prev Cardiol2018; 25: 606–607.
9.
GazianoJMBrotonsCCoppolecchiaRet al.ARRIVE Executive Committee. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet2018; 392: 1036–1046.
10.
SartiniCBarrySJWhincupPHet al.Relationship between outdoor temperature and cardiovascular disease risk factors in older people. Eur J Prev Cardiol2017; 24: 349–356.
11.
ZhaoSChenKSuYet al.Association between patient activity and long-term cardiac death in patients with implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators. Eur J Prev Cardiol2017; 24: 760–767.
12.
TorellMFStromsoeAZagerholmEet al.Higher survival rates in exercise-related out-of-hospital cardiac arrests, compared to non-exercise-related – a study from the Swedish Register of Cardiopulmonary Resuscitation. Eur J Prev Cardiol2017; 24: 1673–1679.
